stock predicts, stock indicies

APDN is a great technical/momentum play, but….this company also has great fundamentals and an incredible story!

APDN is literally the only company in the world that is making use of the complex codes embedded in botanical DNA as the ultimate solution to counterfeiting.

DNA is a trusted form of forensic evidence widely accepted by courts around the world.  Once it is applied onto any surface, DNA resists removal.  The potential for a false positive is basically nonexistant….about one in one trillion.

According to the Coalition Against Counterfeiting and Piracy, “counterfeiting is a pervasive economic and financial crime that costs businesses around the world an estimated $650 billion each year.”

For instance, I came across an article on BusinessWeek.com last week detailing the fact that Hewlett-Packard was going to make anti-piracy efforts once of the company’s top priorities.

Analysts estimate the tech giant’s imaging and printing group lost more than $1 billion in revenue to illegal counterfeits last year.  The company is concerned that shoddy products will do even more damage to its reputation.

“Counterfeit cartridges hurt HP’s business.” says CEO Mark V. Hurd, “More importantly, they hurt our customers who are not getting what they think they are paying for.”

Counterfeit goods also pose a threat to the health and safety of consumers.  According to one of APDN’s partners, “There is always a risk that if you buy a knock-off garment…it could contain harmful dyes…which may be allergenic or even carcinogenic.”

I’ve read reports in recent months that the amount of bogus products being offered on eBay is increasing at an alarming rate.  People think they’re getting great deals, but instead they are paying for counterfeited goods that could cause them harm.

Consumers are being swindled into buying counterfeit luxury items such as high -end clothing, purses, and sunglasses.  It’s an experience that is becoming more prevalent with the rise in popularity of online shopping and a slow economy that has consumers searching for great deals.

Many companies and industries are now turning to APDN’s SigNature DNA and BioMaterial Genotyping to ensure the authenticity of their products and to reduce the potential for counterfeiting and diversion in the market.

APDN’s complete suite of DNA markers and authentication services can help to protect the integrity, quality and security of a wide range of products.  DNA marked security inks, including: intaglio, inkjet, thermal transfer, UV curable, screen printed, flexographic and offset printed inks are now available.

DNA leaves behind a unique forensic signature that can be used to verify the authenticity of a product.  From marking individual packaging to authenticating secure documents, DNA is the only solution that will stand the test of time, and APDN is positioned to become a gargantuan player in this burgeoning industry.

Just do a simple scan of APDN’s press releases and you will see that use of the company’s technology is being applied to an increasing number of situations:

“Applied DNA Sciences Marks Raw Cotton With American Cotton Grower”

“Applied DNA Sciences Uses DNA Authentication To Safeguard Premium Wine Against Counterfeiting and Fraud.”

“Applied DNA Sciences Recovers SigNature DNA From Stolen Cash.”

I think you get the idea!

In my opinion, APDN is a great technical/momentum play but make no mistake about it…the driving force behind APDN’s momentum is definately the company’s technology and its increasing application in the real world.

The Dean is very excited about $IVOB especially after meeting with CEO Katie Karloff in Boston yesterday.

INVO Bioscience (OTCBB: IVOB) is the biotechnology genius behind the patented INVOcell infertility treatment device and the INVO FRANCHISE!

The Dean was quite impressed with $IVOB before but now he’s even more ecstatic to learn about $IVOB’s developments and plans for the future directly from the source!

Both $IVOB and The Dean think their INVO BRAND will be successful because their INVOcell device has the potential to deliver a cost-effective infertility solution to a HUGE MARKET! And because $IVOB’s patented product is a more natural method of in vitro fertilization (IVF) it’s appealing to patients and investors!

Former Boston Scientific (NYSE: BSX) Director of Operations turned $IVOB CEO Katie Karloff is pretty confident that $IVOB is capable of a lot MORE with a lot LESS people! Karloff worked her way up at Boston Scientific (NYSE: BSX) over the course of 13 years and was instrumental in taking the company from an operation with less than 100 employees and $1 million a month in sales to a $30 billion company with 13,000 employees!

The Dean believes that Karloff has already started using her VALUABLE experience working for the biggest medical device company in the world to bring $IVOB public and turn the INVO FRANCHISE into a reality!

The Dean was also excited to learn that Dr. Claude Ranoux, developer of the INVOcell and INVO Procedure, is a pioneer of intra vaginal cultures which harvests the BEST embryos for IVF! And The Dean believes that the 8 years that went into the perfection of the INVOcell will be worth every penny.

In the Boston area, it seems like The Dean isn’t the only one drafting Ivy League Picks because $IVOB plans to acquire two HEAVY HITTERS to beef up their marketing lineup and The Dean will make sure to keep his students posted when the $IVOB team EXPANDS!

$IVOB has already begun building franchises and 7 COUNTRIES are already using their INVOcell device. Dr. Ranoux is currently in South America training 17 physicians, which will MORE THAN TRIPLE the number of centers using the INVO procedure in the world!

The Dean has done his homework and thinks that $IVOB could reap HEAVY PROFITS with their more accessible and less expensive INVO Procedure.

While meeting with $IVOB’s CEO, The Dean learned of the $6 million projection for 2010! And that’s without FDA approval and the American, Chinese and Japanese markets!

Currently there’s 150 million infertile couples in the world. If $IVOB treats just 1% of the infertile population, they could see $500 million in revenues! And $IVOB’s goal is to treat 5%, making that figure closer to a $2.5 billion estimate!

If that happens, The Dean figures a 20 P/E would call for a POTENTIAL BUYOUT of at least $2 billion. That means $IVOB could GROW to $30 to $40 PER SHARE! With $IVOB trading around $0.26 now, investors could gain an 11,000% PROFIT—and that’s on the LOW side!

Projection: Buy EDVP up to $2 before price
goes over $10 after Initial Growth Phase

Endeavor Power is currently expanding its producing well portfolio by 40% per month. I project that the company will have over 150 producing wells by the end of current initial phase.

Endeavor Power’s current estimated resource is 1 million barrels of oil = $70+ million in value. I project that this resource estimate will increase by $30 million per every 10 wells completed.

Endeavor currently trades below $2 and could attain up to $450,000,000 in resource value. I project that early shareholders will be protecting EDVP profits above $10 and holding the rest at much higher prices.

Endeavor’s Advantage to Grow
and Profit at Record-Pace

IMPORTANT: Because of the lowered cost-structure and fast turnaround-times typically associated with this type of petroleum-reactivation program, Endeavor is primed to quickly expand production by several-fold as it targets up to 187 wells through its joint venture with Federated Energy.

I project EDVP can attain up to $450 MILLION in resource value during this current initial phase – which means YOU can expect to protect initial profits well above $10 per share.

Here’s What You’re Getting
RIGHT NOW with Endeavor Power:

At Press-Time, Endeavor Power (EDVP) announced the successful placement of its 14th well into active production at its Patrick Henry Oil Lease, Oklahoma. Endeavor holds a 51% interest in this key U.S. oil reactivation project – with its joint venture partner, Federated Energy Corporation, holding the other 49 percent. The Patrick Henry Lease has estimated recoverable reserves of approximately 1 MILLION barrels of oil.

Even at this very early initial estimate, we’re talking about over $70 MILLION worth of oil in the ground.

Endeavor Power has entered its
Long-Term Growth Phase